National Vision (NASDAQ:EYE) Issues FY 2025 Earnings Guidance

National Vision (NASDAQ:EYEGet Free Report) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 0.620-0.700 for the period, compared to the consensus estimate of 0.570. The company issued revenue guidance of $1.9 billion-$2.0 billion, compared to the consensus revenue estimate of $2.0 billion.

National Vision Stock Performance

Shares of National Vision stock traded up $0.65 during mid-day trading on Friday, hitting $24.13. 2,018,743 shares of the stock were exchanged, compared to its average volume of 2,079,856. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.31 and a current ratio of 0.53. The company has a market capitalization of $1.91 billion, a P/E ratio of -804.07, a P/E/G ratio of 2.74 and a beta of 1.33. The company has a 50-day simple moving average of $25.82 and a 200 day simple moving average of $22.79. National Vision has a 12 month low of $9.93 and a 12 month high of $29.59.

National Vision (NASDAQ:EYEGet Free Report) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.01. The firm had revenue of $487.33 million during the quarter, compared to the consensus estimate of $472.98 million. National Vision had a positive return on equity of 3.58% and a negative net margin of 0.12%.The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.12 EPS. National Vision has set its FY 2025 guidance at 0.620-0.700 EPS. Sell-side analysts anticipate that National Vision will post 0.31 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. UBS Group increased their target price on shares of National Vision from $30.00 to $32.00 and gave the company a “buy” rating in a research report on Thursday. The Goldman Sachs Group increased their price objective on National Vision from $17.00 to $22.00 and gave the company a “neutral” rating in a report on Thursday, August 7th. Barclays decreased their target price on National Vision from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Thursday, August 7th. Wells Fargo & Company set a $27.00 target price on National Vision and gave the company an “equal weight” rating in a research note on Thursday, August 7th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of National Vision in a research note on Wednesday, October 8th. Six investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, National Vision currently has an average rating of “Hold” and a consensus target price of $24.91.

View Our Latest Research Report on EYE

Insider Buying and Selling at National Vision

In other National Vision news, Chairman L Reade Fahs sold 137,400 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The shares were sold at an average price of $24.33, for a total transaction of $3,342,942.00. Following the completion of the sale, the chairman directly owned 544,795 shares of the company’s stock, valued at approximately $13,254,862.35. This represents a 20.14% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.70% of the stock is owned by company insiders.

Institutional Investors Weigh In On National Vision

Several large investors have recently made changes to their positions in the company. Lazard Asset Management LLC increased its holdings in shares of National Vision by 0.9% in the 2nd quarter. Lazard Asset Management LLC now owns 68,819 shares of the company’s stock worth $1,583,000 after buying an additional 637 shares during the last quarter. Captrust Financial Advisors lifted its stake in shares of National Vision by 11.7% in the 2nd quarter. Captrust Financial Advisors now owns 11,463 shares of the company’s stock valued at $264,000 after purchasing an additional 1,200 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of National Vision by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,257 shares of the company’s stock valued at $591,000 after purchasing an additional 1,948 shares during the last quarter. Cerity Partners LLC raised its holdings in National Vision by 13.8% during the 2nd quarter. Cerity Partners LLC now owns 16,887 shares of the company’s stock valued at $389,000 after buying an additional 2,049 shares during the period. Finally, CANADA LIFE ASSURANCE Co lifted its position in National Vision by 2.6% in the second quarter. CANADA LIFE ASSURANCE Co now owns 89,776 shares of the company’s stock worth $2,063,000 after buying an additional 2,243 shares during the last quarter.

National Vision Company Profile

(Get Free Report)

National Vision Holdings, Inc, through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America’s Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services.

Featured Articles

Earnings History and Estimates for National Vision (NASDAQ:EYE)

Receive News & Ratings for National Vision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Vision and related companies with MarketBeat.com's FREE daily email newsletter.